Adaptyv Bio

Adaptyv Bio in the News

4 articles

AI Meets the Lab Bench: Anthropic Bets $1 Million That Claude Can Design Real Proteins
Drug Discovery & Research

AI Meets the Lab Bench: Anthropic Bets $1 Million That Claude Can Design Real Proteins

New competition will experimentally test over 5,000 AI-generated protein designs, building on prior work that achieved a 26.8% success rate in creating functional binders.

Health AI Central Editorial Team·September 18, 2026
Claude AI Slashes Protein Design Costs 100-Fold While Autonomously Rewriting Drug Discovery Code
Drug Discovery & Research

Claude AI Slashes Protein Design Costs 100-Fold While Autonomously Rewriting Drug Discovery Code

Anthropic's foundation model optimized 36 biomolecular AI packages in under four weeks, achieving 4x speed gains and enabling therapeutic design for $150 instead of $10,000 per target.

Health AI Central Editorial Team·September 18, 2026
Claude AI Outperforms Human Scientists in Protein Design Competition, Validating 354 Functional Binders
Drug Discovery & Research

Claude AI Outperforms Human Scientists in Protein Design Competition, Validating 354 Functional Binders

Anthropic's general-purpose AI achieved hit rates up to 35% in lab-validated protein engineering tests—more than double the industry standard—while analyzing complex chemistry data in minutes instead of days.

Health AI Central Editorial Team·August 22, 2026
AI Agent Designs 354 Protein Binders in 48 Hours, Doubling Industry Success Rates
Drug Discovery & Research

AI Agent Designs 354 Protein Binders in 48 Hours, Doubling Industry Success Rates

Anthropic's autonomous models orchestrated existing computational tools to generate high-affinity binders across oncology targets, achieving hit rates up to 35% compared to a 10-15% field norm.

Health AI Central Editorial Team·August 22, 2026